Neuralink has expanded its Patient Registry beyond the borders of the US to include residents of Canada. This move broadens the scope of potential participants in Neuralink’s groundbreaking clinical trials and is a step forward in the company’s mission to enhance human capabilities through advanced neural technologies.
Neuralink, known for its ambitious projects aimed at bridging the gap between the human brain and computers, made the announcement via its official X account, inviting Canadian residents to join its journey towards innovation.
🇨🇦 Our Patient Registry is now open to Canadian residents! Join us in shaping the future of brain-computer interfaces by learning more and applying today https://t.co/0RSxWdQy0b. https://t.co/WvTeobmCbt
— Neuralink (@neuralink) March 23, 2024
According to Neuralink’s website, the eligibility criteria for the Patient Registry target a wide range of conditions such as quadriplegia, paraplegia, vision and hearing loss, aphasia, and major limb amputation. Applicants must be at least 18 years old and meet the age of majority in their respective province or territory. While enrollment in the Patient Registry does not guarantee participation in future clinical trials, it is a vital step in identifying potential candidates for Neuralink’s innovative treatments.
The Patient Registry, initially open to US residents, is designed to gather a diverse group of individuals who can contribute to the development and refinement of Neuralink’s devices. These devices are intended to address the needs of people with various neurological conditions, offering new hope for enhanced communication, mobility, and sensory experiences.
The expansion of the Patient Registry to Canada is a precursor to Neuralink’s intention to conduct clinical trials in the country, aiming to validate the efficacy and safety of its technology on a broader scale.
If you meet these criteria and are interested, you can apply here.
The announcement comes on the heels of Neuralink’s recent live stream, which showcased the capabilities of its Telepathy device in a real-world scenario. The device enables users to control digital interfaces with their thoughts alone. The company’s first human patient, Noland Arbaugh, demonstrated the device’s potential by playing chess on his computer without the physical use of his hands, likening the experience to wielding “the Force” from Star Wars.
— Neuralink (@neuralink) March 20, 2024
